UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 811

Sortiert nach

Meta-analysis of radical resection rates and margin assessment in pancreatic cancer

British journal of surgery, 2015-11, Vol.102 (12), p.1459-1472

2015

Volltextzugriff (PDF)

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial

The Lancet (British edition), 2007-11, Vol.370 (9600), p.1687-1697

2007

Volltextzugriff (PDF)

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Annals of oncology, 2020-11, Vol.31 (11), p.1553-1560

2020

Volltextzugriff (PDF)

Publication bias: evidence of delayed publication in a cohort study of clinical research projects

BMJ (Online), 1997-09, Vol.315 (7109), p.640

International edition, 1997

Volltextzugriff (PDF)

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

Diabetologia, 2011-02, Vol.54 (2), p.280-290

2011

Volltextzugriff (PDF)

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

British journal of cancer, 2014-02, Vol.110 (3), p.648-655

2014

Volltextzugriff (PDF)

Challenges of international oncology trial collaboration-a call to action

British journal of cancer, 2019-10, Vol.121 (7), p.515-521

2019

Volltextzugriff (PDF)

Harnessing Real-World Evidence to Advance Cancer Research

Current oncology (Toronto), 2023-02, Vol.30 (2), p.1844-1859

2023

Volltextzugriff (PDF)

Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer

British journal of cancer, 2015-06, Vol.113 (1), p.37-45

2015

Volltextzugriff (PDF)

A systematic review of taxane-containing regimens for metastatic breast cancer

British journal of cancer, 2005-08, Vol.93 (3), p.293-301

2005

Volltextzugriff (PDF)

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C

Annals of oncology, 2012-06, Vol.23 (6), p.1531-1536

2012

Volltextzugriff (PDF)

Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines

Annals of oncology, 2014-01, Vol.25 (1), p.117-121

2014

Volltextzugriff (PDF)

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

BMC cancer, 2022-03, Vol.22 (1), p.276-276, Article 276

2022

Volltextzugriff (PDF)

Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration

JAMA : the journal of the American Medical Association, 2018-06, Vol.319 (21), p.2190

2018

Volltextzugriff (PDF)

Protocol for analyses of adverse event data from randomized controlled trials of statin therapy

The American heart journal, 2016-06, Vol.176, p.63-69

2016

Volltextzugriff (PDF)

Approaches to prioritising research for clinical trial networks: a scoping review

Trials, 2022-12, Vol.23 (1), p.1000-1000, Article 1000

2022

Volltextzugriff (PDF)

Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial

JNCI : Journal of the National Cancer Institute, 2009-09, Vol.101 (17), p.1182-1192

2009

Volltextzugriff (PDF)

Clinical characteristics and outcome of patients with early (<2h), intermediate (2–4h) and late (>4h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction

European heart journal, 2002-04, Vol.23 (7), p.550-557

2002

Volltextzugriff (PDF)

Common genetic variants do not predict recurrent events in coronary heart disease patients

BMC cardiovascular disorders, 2022-03, Vol.22 (1), p.96-96, Article 96

2022

Volltextzugriff (PDF)

Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trial

Journal of clinical neuroscience, 2021-12, Vol.94, p.321-327

2021

Volltextzugriff (PDF)

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer

Annals of oncology, 2013-04, Vol.24 (4), p.937-943

2013

Volltextzugriff (PDF)

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

Annals of oncology, 2005-11, Vol.16 (11), p.1786-1794

2005

Volltextzugriff (PDF)

Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer

British journal of cancer, 2015-03, Vol.112 (6), p.963-970

2015

Volltextzugriff (PDF)

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes

Diabetologia, 2010-09, Vol.53 (9), p.1846-1855

2010

Volltextzugriff (PDF)

1 – 25 von 811

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(624)
Mit Volltextzugriff
(731)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(397)
Life Sciences & Biomedicine
(329)
Humans
(307)
Female
(212)
Male
(168)
Middle Aged
(161)
Biological And Medical Sciences
(153)
Aged
(151)
Medical Sciences
(146)
Oncology
(102)
Adult
(95)
Clinical Trials
(76)
Treatment Outcome
(74)
General & Internal Medicine
(73)
Medicine, General & Internal
(70)
Cardiovascular System & Cardiology
(62)
Randomized Controlled Trials As Topic
(61)
Pharmacology. Drug Treatments
(59)
Risk Factors
(59)
Physical Sciences
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Meta-analysis of radical resection rates and margin assessment in pancreatic cancer

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Publication bias: evidence of delayed publication in a cohort study of clinical research projects

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

Challenges of international oncology trial collaboration-a call to action

Harnessing Real-World Evidence to Advance Cancer Research

Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer

A systematic review of taxane-containing regimens for metastatic breast cancer

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C

Final results of Australasian Gastrointestinal Trials Group ARCTIC study: an audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines

Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial

Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma

Association Between Oxygen Saturation Targeting and Death or Disability in Extremely Preterm Infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration

Protocol for analyses of adverse event data from randomized controlled trials of statin therapy

Approaches to prioritising research for clinical trial networks: a scoping review

Prospective Cost-Effectiveness Analysis of Cetuximab in Metastatic Colorectal Cancer: Evaluation of National Cancer Institute of Canada Clinical Trials Group CO.17 Trial

Clinical characteristics and outcome of patients with early (<2h), intermediate (2–4h) and late (>4h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction

Common genetic variants do not predict recurrent events in coronary heart disease patients

Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trial

A prognostic nomogram to predict overall survival in patients with platinum-sensitive recurrent ovarian cancer

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?

Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer

Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes

Suchergebnisse filtern